Conflict of Interest
This site contains resources pertaining to financial conflict of interest. If you have questions or need assistance with a specific situation, please contact Carole Cole at 257-0579 or clcole2@uky.edu.
AR II-4.0-4 Conflict of
Interest/Financial Disclosure Policy – Research
Disclosure Form
AR II-1.1-1 Consulting and Other
Overload Employment
University of Kentucky E thics Policy
UK Business Procedures, Section B- 2 Purchasing, Paragraph C
KRS 164.390
NIH Frequently Asked Questions
Public Health Service (PHS) and National Science Foundation (NSF), Federal
Register July 11, 1995
Q&A of PHS and NSF policies, Federal Register July 3, 1996
PHS Policy Title 42, Part 50, Subpart F
National Institutes of Health (NIH) Grants Policy Statement
NSF Proposal and Award Policies and Procedures Guide, Chapter IVA
Food and Drug Administration (FDA), Code of Federal Regulations Title 21, Chapter 1, Part 54
Key Reports and Policy Guidance
Associated of American Medical Colleges and the American Universities Advisory Committee on Financial COI in Human Subjects Research Report, February, 2008
Federation of American Societies for Experimental Biology, "COI Toolkit," July, 2007
National Institutes of Health, A Working Group of the Advisory Committee to the Director, “Report of the National Institutes of Health Blue Ribbon Panel on Conflict of Interest Policies,” June 22, 2004
Department of Health and Human Services (DHHS), "Financial
Relationships and Interest in Research Involving Human Subjects: Guidance
for Human Subject Protection," May 2004
Council on Governmental Relations, “Approaches to Developing an
Institutional Conflict of Interest Policy,” Fall 2003 (Hard copy available to University of Kentucky employees upon
request)
Council on Governmental Relations, “Recognizing and Managing Personal
Financial Conflicts of Interest,” Winter 2002 (Hard copy available to University of Kentucky employees upon
request)
Association of American Medical Colleges (AAMC), “Protecting Subjects,
Preserving Trust, Promoting Progress II: Principles and Recommendations for Oversight of an Institution’s
Financial Interests in Human Subjects Research,” October 2002
Association of American Universities (AAU), “Report on Individual and
Institutional Financial Conflict of Interest,” October 2001
AAMC, “Protecting Subjects, Preserving Trust, Promoting Progress –
Policy and Guidelines for the Oversight of Individual Financial Interests in
Human Subjects Research,” December 2001
Government Accounting Office (GAO), Report to the Ranking Minority Member,
Subcommittee on Public Health, Committee on Health, Education, Labor, and
Pensions, U.S. Senate, “Biomedical Research, HHS Direction Needed to
Address Financial Conflicts of Interest,” November 2001
FDA "Guidance: Financial Disclosure by Clinical Investigators"
(March 20, 2001)
Office for Human Research Protections, Draft Interim Guidelines,
“Financial Relationships in Clinical Research: Issues for Institutions,
Clinical Investigators, and IRBs to Consider when Dealing with Issues of
Financial Interests and Human Subject Protection,” January 2001
AAMC Guidelines for Dealing with Faculty Conflicts of Commitment and Conflicts
of Interest in Research (Adopted by the Executive Council of the AAMC
February 22, 1990)